尼莫地平联合醒脑静治疗高血压脑出血患者的临床效果

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of Nimodipine on serum neurotransmitters in hypertensive intracerebral hemorrhage and its prognostic.Methods From June 2016 to June 2017,108 patients with hypertensive intracerebral hemorrhage were diagnosed in our hospital were selected as subjects.They were divided into observation group(56 cases)and control group (52 cases)according to different medication schemes.The patients in the observation group were treated with Nimodipine combined with Xingnaojing,and the control group was treated with the treatment of Edaravone and Xingnaojing,and two courses of treatment were successively treated.The serum neurotransmitter indexs,neurofunctional indexs,survival quality score and therapeutic effect were compared between the two groups.Results After two courses of treatment,the vasopressin([7.18±1.59]ng/L),glial fibrillary acidic protein([7.28±2.16]ng/L),glutamate([77.57±3.59]μmol/L)μmol/L,aspartic acid([28.69±3.67]μmol/L),S100B protein([0.44±0.06]ng/L),neuropeptide Y([177.45±11.07]μg/L),neuron-specific enolase([10.19±2.65]mg/L)in the observation group were significantly lower than those in the control group ([10.27±3.01]ng/L,[13.24±2.62]ng/L,[84.34±6.52]μmol/L,[37.95±4.95]μmol/L,[0.87±0.31]ng/L,[196.34±12.64]μg/L,[16.08±4.12]mg/L),while the γ-aminobutyrate([4.25±1.02]μmol/L)and brain origin neurotrophic factor([6.21±1.26]ng/mL)in the observation group were significantly higher than those in the control group ([3.41±0.58]μmol/L,(5.13±1.05]ng/mL),and the differences were statistically significant(P＜0.05).The total score of world health organization survival quality measurement scale (WHOQOL-100)in the observation group was (78.55±7.53)points,which was significantly higher than that in the control group (71.05±6.15)points,and the difference was statistically significant(P＜0.05).The effective rate of treatment in the observation group(89.29%)was significantly higher than that in the control group(80.77%),and the difference was statistically significant(P＜0.05).Conclusion Nimodipine and Xingnaojing are suitable for the treatment of hypertensive intracerebral hemorrhage.It can effectively regulate the expression level of serum neurotransmitters,promote the recovery of nerve function,and have a good prognosis.

Key words： Nimodipine Hypertensive intracerebral hemorrhage Serum neurotransmitters Xingnaojing injection Nerve function

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GENG Yu

Cite this article:

GENG Yu. Effect of Nimodipine combined with Xingnaojing for the treatment of hypertensive intracerebral hemorrhage[J]. 中国当代医药, 2018, 25(9): 83-86.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I9/83

[1]	段淑霞，刘涛，王戬萌.尼莫地平对不同时间点高血压脑出血患者血清炎性因子影响的实验研究[J].中国实验诊断学，2015，19（7）：1065-1067.
[2]	王伟伟，康玲，田永青，等.醒脑静联合依达拉奉治疗高血压脑出血的疗效分析[J].广西医科大学学报，2017，34（3）：445-447.
[3]	钟波，刘艳红，田烜.立体定向血肿穿刺抽吸术联合醒脑静注射液治疗高血压脑出血的临床研究[J].中国现代医学杂志，2015，25（4）：60-63.
[4]	路楷，徐彬彬，查海峰，等.高血压脑出血外科治疗与预后的相关性分析[J].中华神经外科疾病研究杂志，2014，13（4）：354-356.
[5]	徐海松，胡燕侠，姜启周.盐酸氨溴索治疗高血压脑出血患者术后肺部感染的临床研究[J].中华医院感染学杂志，2014，24（1）：185-187.
[6]	陈化，王忠安，黎开谷，等.依达拉奉联合尼莫地平治疗高血压脑出血的疗效研究[J].临床合理用药杂志，2015，7（35）：2197-2198.
[7]	杨鹤云，杨正宇，张红莲，等.尼莫地平对高血压脑出血患者脑血肿、水肿及神经功能恢复的影响[J].中国医药科学，2015，5（1）：121-123.
[8]	刘爽，王福莉，詹奇，等.脉络宁注射液联合依达拉奉和尼莫地平治疗高血压脑出血疗效观察[J].中医药信息，2017，34（1）：96-98.
[9]	李旭，李志祥，宋明浩，等.高血压脑出血患者不同手术时机与术后再出血的关系[J].中国药物经济学，2016，（1）：111-113.
[10]	谢顺清.尼莫地平持续泵入治疗高血压脑出血的效果观察[J].中国实用神经疾病杂志，2014，17（15）：18-19.
[11]	朱永生，马龙，马晓珉.高原地区高血压脑出血患者早期高压氧治疗临床观察[J].中国实用神经疾病杂志，2016，19（21）：46-48.
[12]	童民锋，刘继红，戴海斌.醒脑静注射液对高血压脑出血患者临床指标的影响[J].中国临床药理学杂志，2016，32（5）：399-401.
[13]	龙勇，曾春，唐爽，等.高压氧联合药物治疗对高血压脑出血康复期脑血流特征、神经损伤程度及神经细胞因子的影响[J].海南医学院学报，2017，23（14）：1995-1998.
[14]	黄毅，黄纯真，赵霞.高血压脑出血内镜手术治疗进展[J].中华神经外科疾病研究杂志，2014，13（5）：472-474.
[15]	李建辉，王化贤，许红霞，等.尼莫地平预防高血压脑出血血肿扩大的临床研究[J].中国医药指南，2014，12（20）：237-238.
[16]	王清芳，冯玉凤.神经节苷脂联合尼莫地平治疗高血压脑出血的疗效及对神经功能恢复的影响[J].中国实用神经疾病杂志，2017，20（1）：108-110.
[17]	王鹤，郑兆聪，陈宏颉，等.高血压脑出血早期血肿扩大的预测指标及防治手段[J].中华神经医学杂志，2014，13（10）：1074-1077.
[18]	蔡卫卫，吕建周，王化贤，等.静脉泵控尼莫地平治疗高血压脑出血临床研究[J].中国实用神经疾病杂志，2015，18（15）：35-37.
[19]	李永峰，李伟.微创血肿清除术联合醒脑静治疗对高血压脑出血患者神经功能损伤及细胞因子含量的影响[J].海南医学院学报，2017，23（6）：827-830.
[20]	姚书燕，刘海花，韩文颖，等.肌氨肽苷联合不同剂量醒脑静对高血压脑出血的疗效及对神经功能缺损的改善效果[J].中国实用神经疾病杂志，2016，19（13）：51-53.